Initial respiratory management in preterm infants and bronchopulmonary dysplasia

Clinics

Volumn 66, Issue 5, 2011, Pages 823-827

  López, Ester Sanz ^a   Rodríguez, Elena Maderuelo ^a   Navarro, Cristina Ramos ^a   Sánchez Luna, Manuel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Bronchopulmonary dysplasia; Initial; Nasal cpap; Preterm; Respiratory support; Surfactant

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; FEMALE; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; MALE; MORTALITY; NEWBORN; PREMATURITY; PROSPECTIVE STUDY; UTILIZATION REVIEW;

BRONCHOPULMONARY DYSPLASIA; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL;

EID: 79960753768     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000500019     Document Type: Article

References (28)

1. Jobe AH. The new BPD: an arrest of lung development. Pediatr Res. 1999;46:641-3 doi: 10.1203/00006450-199912000-00001.
2. Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:179-84 doi: 10.1053/j.semperi.2006.05.004.
3. Bancalari E, Claure N. Definitions and diagnostic criteria for bronchopulmonary dysplasia. Semin Perinatol. 2006;30:164-70 doi: 10.1053/j. semperi.2006.05.002.
4. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. NICHD-NHLBIORD Workshop. Am J Respir Crit Care Med. 2001;163:1723-9.
5. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for The Developmental Network. Pediatrics. 2000;105:1194-201 doi: 10.1542/peds.105.6.1194.
6. Mulrooney N, Champion Z, Moss TJ, Nitsos I, Ikegami M, Jobe AH. Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure. Am J Respir Crit Care Med. 2005;171:488-93 doi: 10.1164/rccm.200406-774OC.
7. Jobe AH, Kramer BW, Moss TJ, Newnham JP, Ikegami M. Decreased indicators of lung injury with continuous positive airway pressure in preterm lambs. Pediatr Res. 2002;52:387-92.
8. Probyn ME, Hooper SB, Dargaville PA, McCallion N, Crossley K, Harding R, et al. Positive end-expiratory pressure during resuscitation of premature lambs rapidly improves blood gases without adversely affecting arterial pressure. Pediatr Res. 2004;56:198-204 doi: 10.1203/ 01.PDR.0000132752.94155.13.
9. Jonsson B, Katz-Salamon M, Faxelius G, Broberger U, Lagercrantz H. Neonatal care of very low birthweight infants in special care units and neonatal intensive care units in Stockholm. Early nasal continuous positive airway pressure versus mechanical ventilation; gains and losses. Acta Pediatr Suppl. 1997;419:4-10.
10. Gittermann MK, Fusch C, Gittermann AR, Regazzoni BM, Moessinger AC. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birthweight infants. Eur J Pediatr. 1997;156:384-8.
11. de Klerk AM, de Klerk RK. Nasal continuous positive airway pressure and outcomes in preterm infants. J Paediatr Child Health. 2001;37:161 doi: 10.1046/j.1440-1754.2001.00624.x.
12. Finer NN, Carlo WA, Duara S, Fanaroff AA, Donovan EF, Wright LL, et al. Delivery room continuous positive airway pressure/positive end expiratory pressure in extremely low birthweight infants: A feasibility trial. Pediatrics. 2004;114:651-7 doi: 10.1542/peds.2004-0394.
13. Jobe AH, Hillman N, Polglase G, Kramer BW, Kallapur S, Pillow J. Injury and inflammation from resuscitation of the preterm infant. Neonatology. 2008;94:190-6 doi: 10.1159/000143721.
14. Geary C, Caskey M, Fonseca R, Malloy M. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study. Pediatrics. 2008;121:89-96 doi: 10.1542/peds.2007-0225.
15. Jobe AH, Ikegami M. Prevention of bronchopulmonary dysplasia. Curr Opin Pediatr. 2001;13:124-9 doi: 10.1097/00008480-200104000-00006.
16. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrøm K, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med. 1994;331:1051-5.
17. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics. 1999;103:E24 doi: 10.1542/peds.103.2.e24,-1,xxx/2.e24.
18. Mark SP, Croughan-Minihane MS, Kilpatrick SJ. Chorioamnionitis and uterine function. Obstet Gynecol. 2000;95:909-12 doi: 10.1016/S0029-7844(00)00816-4.
19. Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol. 2003;23:451-6 doi: 10.1038/sj.jp.7210963.
20. Walsh MC, Gettner P, Yao Q, Hale E, Collins M, Hensman A, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114:1305-11 doi: 10.1542/peds.2004-0204.
21. Björklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res. 1997;42:348-55 doi: 10.1203/00006450-199709000-00016.
22. Verder H. Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome. Acta Paediatr. 2007;96:482-4 doi: 10.1111/j.1651-2227.2007.00263.x.
23. Aly H, Milner JD, Patel K, El-Mohandes AAE. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants? Pediatrics. 2004;114;697-702 doi: 10.1542/peds.2003-0572-L.
24. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008;358:700-8.
25. Ammari A, Suri M, Milisavljevic V, Sahni R, Bateman D, Sanocka U, et al. Variables associated with the early failure of nasal CPAP in very low birth weight infants. The Journal of Pediatrics. 2005;147;341-7 doi: 10. 1016/j.jpeds.2005.04.062.
26. Verder H, Bohlin K, Kamper J, Lindwall R, Jonsson B. Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia. Acta Paediatr. 2009;98:1400-8 doi: 10. 1111/j.1651-2227.2009.01413.x.
27. Kurkinen-Raty M, Koivisto M, Jouppila P. Preterm delivery for maternal or fetal indications: maternal morbidity, neonatal outcome and late sequelae in infants. BJOG. 2000;107:648-55 doi: 10.1111/j.1471-0528.2000. tb13308.x.
28. Hansen AR, Barne ́s CM, Folkman J, Mc Elrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr. 2010;156:532-6 doi: 10.1016/j.jpeds.2009.10.018.